0 106

Cited 0 times in

Phase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial

DC Field Value Language
dc.date.accessioned2023-06-02T01:05:41Z-
dc.date.available2023-06-02T01:05:41Z-
dc.date.issued2022-06-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194647-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePhase 1 trial of vibostolimab plus pembrolizumab for PD-1/PD-L1 inhibitor-naive advanced gastric cancer: The KEYVIBE-001 trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorK. Shitara-
dc.contributor.googleauthorT. Golan-
dc.contributor.googleauthorK. Mileham-
dc.contributor.googleauthorM. Voskoboynik-
dc.contributor.googleauthorS. Rha-
dc.contributor.googleauthorM. Gutierrez-
dc.contributor.googleauthorR. Perets-
dc.contributor.googleauthorS. Taylor-
dc.contributor.googleauthorD. Chen-
dc.contributor.googleauthorT. Keenan-
dc.contributor.googleauthorM. Rajasagi-
dc.contributor.googleauthorJ. Healy-
dc.contributor.googleauthorH. Shoji-
dc.identifier.doi10.1016/j.annonc.2022.04.081-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422007712-
dc.citation.volume33-
dc.citation.numberSuppl 4-
dc.citation.startPageS240-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Suppl 4) : S240, 2022-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.